Integrated Drug Discovery for Small Molecules and Emerging Modalities

Sai Life Sciences advances drug discovery through integrated chemistry, biology, DMPK, pharmacology, and safety capabilities operating within coordinated workflows. Programs are designed to progress from hit identification through IND-enabling stages with scientific rigor, data-driven decision-making, and cross-disciplinary alignment.

Whether delivered as a fully integrated discovery program or as focused functional services, our model enables efficient candidate progression while maintaining continuity into downstream CMC development. Our expanding expertise includes next-generation therapeutic approaches such as targeted protein degradation and related emerging modalities.

Our Capabilities

Integrated Drug Discovery

Coordinated end-to-end programs integrating chemistry, biology, DMPK, pharmacology, and safety to advance candidates from hit identification through IND-enabling stages.

CADD & Structural Biology

Structure-guided design and computational modeling approaches that inform target validation, hit expansion, and lead optimization strategies.

Synthetic & Medicinal Chemistry

Design and synthesis of complex small molecules supported by SAR-driven optimization to refine potency, selectivity, and developability

In Vitro Biology

Fit-for-purpose biochemical and cell-based assays aligned to target biology, enabling data-driven compound progression.

DMPK

In vitro ADME and in vivo pharmacokinetic studies designed to optimize exposure, stability, and overall drug-like properties.

In Vivo Pharmacology

Translational disease models with biomarker integration to support efficacy evaluation and candidate differentiation.

Safety & Toxicology

Early safety assessment and decision-enabling toxicology studies to identify liabilities and reduce downstream risk.

Compound Management

Centralized compound handling and tracking systems integrated within discovery workflows to ensure data integrity and operational continuity.

The Sai Difference

Discovery at Sai Life Sciences is structured to integrate scientific disciplines early, reduce late-stage risk, and enable seamless progression into development and manufacturing phases. We also bring together scientific depth, operational scale, and integrated discovery capabilities to advance programs efficiently.

Integrated Drug Discovery for Small Molecules and Emerging Modalities

Our Capabilities